Significantly higher serum ANGPTL4 level was observed in the AIS group compared with the healthy control group (p = 0.003), with level in the AIS group at 1113.30 pg/mL (interquartile range [IQR]: 673.42–1967.50 pg/mL), and in the healthy control group at 876.18 pg/mL (IQR: 571.68–1523.05 pg/mL). The gene discussed is ANGPTL4; the disease is androgen insensitivity syndrome.